Going back to my earlier post (below), it was good to see Amagen (and Pfizer) was welcomed into the Dow Jones index for the first time today. It knocked Exxon out of the tightly held index and its coming close to a US$150 B for Billion market cap. Amagen's star drug is its anti cholesterol drug, Repatha which Nyrada is hoping to knock off its perch. Pfizer is also one of the big pharmas that havent acquired a drug for the anti cholesterol market yet either.
https://hotcopper.com.au/threads/ann-nyrada-brain-injury-data-published-by-us-health-conference.5492559/page-4?post_id=45759244
Food for thought only.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.025(10.0%) |
Mkt cap ! $47.45M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 22.5¢ | $209.3K | 892.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7150 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 416666 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |